• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Argentina Pharmaceuticals and Healthcare Report Q2 2009 - Product Image

Argentina Pharmaceuticals and Healthcare Report Q2 2009

  • ID: 992505
  • April 2009
  • Region: Argentina
  • 91 Pages
  • Business Monitor International

FEATURED COMPANIES

  • Boehringer Ingelheim
  • GlaxoSmithKline (GSK)
  • Laboratorios Bagó
  • Laboratorios Roemmers
  • Merck & Co
  • Novartis
  • MORE

The Argentina Pharmaceuticals and Healthcare Report provides independent forecasts and competitive intelligence on Argentina's pharmaceuticals and healthcare industry.

Argentina remains ranked just eighth among the 10 major pharmaceutical markets surveyed in the Q209 Business Environment Ratings. While the country’s substantial and growing population theoretically represents a strong draw for foreign companies, the government’s lax stance on bioequivalance has resulted in many multinationals choosing to close down their local production facilities. The lack of patent protection, the imposition of strict price controls, and the government’s bias towards local producers in its purchasing policies are among the most frequent complaints levelled against the country’s operating environment. Consequently, without major improvements in intellectual property (IP) and pricing rules, the larger and better-regulated markets of Brazil, Mexico and even Colombia will continue to attract the lion’s share of multinational investment in the region, Moreover, despite double-digit growth rates experienced in 2006 and 2007, all the more important given the economic READ MORE >

FEATURED COMPANIES

  • Boehringer Ingelheim
  • GlaxoSmithKline (GSK)
  • Laboratorios Bagó
  • Laboratorios Roemmers
  • Merck & Co
  • Novartis
  • MORE

EXECUTIVE SUMMARY
Argentina Pharmaceuticals And Healthcare Industry SWOT
Argentina Political SWOT
Argentina Economic SWOT
Argentina Business Environment SWOT

PHARMACEUTICAL BUSINESS ENVIRONMENT RATINGS
Table: Americas Pharmaceutical Business Environment Rankings
Limits Of Potential Returns
Risks To Realisation Of Returns

ARGENTINA – MARKET SUMMARY

REGULATORY REGIME
OTC Regulation
Recent Regulatory Developments
Intellectual Property (IP) Environment
IP Disputes
Table: Joint Declaration By Latin American Health Ministers, May 2006
Counterfeit Pharmaceuticals
Pricing Regime
Table Argentina - Pharmaceutical Price Build-Up
Table: Argentina’s Drug Price Freeze, 2005-2008
Reimbursement Regime

INDUSTRY TRENDS AND DEVELOPMENTS
Epidemiology
Healthcare Insurance
Recent Healthcare Insurance Developments
Domestic Pharmaceutical Sector
Recent Developments in Domestic Pharmaceuticals Sector
Multinational Sector Developments
Vaccines Sector
Recent Developments in the Vaccines Sector
Medicinal Plants
Table Argentina - Imports of Medicinal Plants by Country (US$'000)
Research and Development (R&D)
Clinical Trials
Medical Devices

INDUSTRY FORECAST SCENARIO
Overall Market Forecast
Table: Argentina - Drug Market Indicators, Historical Data and Forecasts
Key Growth Factors – Industry
Table: Argentina – Health Expenditure Indicators, Historical Data and Forecasts
Key Growth Factors – Macroeconomic
Table: Argentina - Economic Activity
Prescription Market Forecast
Table: Argentina - Prescription Drug Market Indicators, Historical Data and Forecasts (ARSmn unless otherwise stated)
Patented Market Forecast
Table: Argentina – Patented Market Indicators, Historical Data and Forecasts
Generics Market Forecast
Table: Argentina – Generics Market Indicators , Historical Data and Forecasts
OTC Market Forecasts
Table: Argentina – OTC** Market Indicators, Historical Data and Forecasts (ARSmn unless otherwise stated)
Pharmaceutical Trade Forecasts
Table Argentina – Imports of Medicines Containing Vitamins by Country (US$'000)
Table: Argentina - Pharmaceutical Trade Indicators, Historical Data and Forecasts (US$mn)
Medical Device Market Forecast
Table: Argentina – Medical Device Market Indicators, Historical Data and Forecasts (US$mn unless otherwise stated)
Other Healthcare Data Forecasts
Table: Argentina – Other Health Indicators, Historical Data and Forecasts
Key Risks To BMI’s Forecast Scenario

COMPETITIVE LANDSCAPE

COMPANY MONITOR
Leading Foreign Companies
Pfizer
Roche
Novartis
GlaxoSmithKline (GSK)
Sanofi-Aventis
Merck & Co
Boehringer Ingelheim
Indigenous Manufacturers
Laboratorios Roemmers
Laboratorios Bagó

COUNTRY SNAPSHOT: ARGENTINA DEMOGRAPHIC DATA
Section 1: Population
Table: Demographic Indicators, 2005-2030
Table: Rural/Urban Breakdown, 2005-2030
Section 2: Education And Healthcare
Table: Education
Table: Life Expectancy, 2005-2030
Section 3: Labour Market And Spending Power
Table: Employment Indicators, 2001-2006
Table: Consumer Expenditure, 2000-2012 (US$)
Table: Average Annual Manufacturing Wages, 1995-2001

BMI FORECAST MODELLING
How We Generate Our Pharmaceutical Industry Forecasts
Pharmaceutical Business Environment Ratings Methodology
Ratings Overview
Table: Pharmaceutical Business Environment Indicators
Weighting
Table: Weighting Of Components
Sources

- Pfizer

- Roche

- Novartis

- GlaxoSmithKline (GSK)

- Sanofi-Aventis

- Merck & Co

- Boehringer Ingelheim

- Laboratorios Roemmers

- Laboratorios Bagó

Note: Product cover images may vary from those shown

ALSO AVAILABLE

RELATED PRODUCTS

Our Clients

Our clients' logos